Collectively, our findings suggest that SHIP-1 restrains microglial activation, and given that chronically activated microglia and augmented brain cytokines are considered pathogenic for neurodegenerative diseases and psychiatric disorders [86], further assessment into how SHIP-1 regulates these processes is warranted. This evidence concerns the gene INPP5D and psychiatric disorder.